Loading…
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients
Tang, Bixia, Yan, Xieqiao, Sheng, Xinan, Si, Lu, Cui, Chuanliang, Kong, Yan, Mao, Lili, Lian, Bin, Bai, Xue, Wang, Xuan, Li, Siming, Zhou, Li, Yu, Jiayi, Dai, Jie, Wang, Kai, Hu, Jinwei, Dong, Lihou, Song, Haifeng, Wu, Hai, Feng, Hui, Yao, Sheng, Chi, Zhihong, Guo, Jun
Published in Journal of hematology and oncology (14.01.2019)
Published in Journal of hematology and oncology (14.01.2019)
Get full text
Journal Article
Loading…
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy
Susok, L., Said, S., Reinert, D., Mansour, R., Scheel, C. H., Becker, J. C., Gambichler, T.
Published in Journal of cancer research and clinical oncology (01.11.2022)
Published in Journal of cancer research and clinical oncology (01.11.2022)
Get full text
Journal Article
Loading…
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Borzillo, Valentina, Giugliano, Francesca Maria, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Palmieri, Giuseppe, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Published in Oncoimmunology (01.05.2014)
Published in Oncoimmunology (01.05.2014)
Get full text
Journal Article
Loading…
Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma
Albertini, Mark R., Morris, Zachary Scott, Hank, Jacquelyn A, Ranheim, Erik, Zuleger, Cindy L, McDowell, Kimberly, Quale, Renae M, Monson, Molly, Clements, Erin, Koehn, Tamara, Neuman, Heather B., Weber, Sharon M., Racz, Jennifer, Henry, Mary Beth, Reinstad, Emily, Kim, KyungMann, Gillies, Stephen D., Sondel, Paul M.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Loading…
A first-in-human, phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of neoadjuvant use of ph-762 administered intratumorally in subjects with advanced melanoma
Robert, Caroline, Roy, Severine, Cuiffo, Benjamin, Cardia, James, Fricker, Simon Paul
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Risk factors and predictive models for early death in patients with advanced melanoma: A population-based study
Li, Siru, Yin, Cunli, Yang, Xi, Lu, Yingchun, Wang, ChunYu, Liu, Bin
Published in Medicine (Baltimore) (06.10.2023)
Published in Medicine (Baltimore) (06.10.2023)
Get full text
Journal Article
Loading…
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma
Mallardo, Domenico, Fordellone, Mario, Ottaviano, Margaret, Marano, Giuseppina, Vitale, Maria Grazia, Mallardo, Mario, Capasso, Mariagrazia, De Cristofaro, Teresa, Capone, Mariaelena, Meinardi, Teresa, Paone, Miriam, Sabatelli, Patrizia, De Filippi, Rosaria, Cesano, Alessandra, Cavalcanti, Ernesta, Caracò, Corrado, Warren, Sarah, Budillon, Alfredo, Simeone, Ester, Ascierto, Paolo Antonio
Published in International journal of molecular sciences (19.11.2024)
Published in International journal of molecular sciences (19.11.2024)
Get full text
Journal Article
Loading…
Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma
Pecora, Andrew L, Rapisuwon, Suthee, Chen, Kevin, Gardner, Kellie, Cramer, Gayle, Blair, Danielle, Avergas, Amy, Swanson, Nicole, Ahn, Jaeil, Atkins, Michael B.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
A phase 1 first-in-human dose finding/randomized phase 2 study of IMM60 and pembrolizumab (PEM) in advanced melanoma and non-small cell lung cancer (NSCLC; IMP-MEL)
Coupe, Nicholas, Walters, Ian B., Kramer, Robert A., Gileadi, Uzi, Middleton, Mark R.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
Di Giacomo, A.M., Ascierto, P.A., Queirolo, P., Pilla, L., Ridolfi, R., Santinami, M., Testori, A., Simeone, E., Guidoboni, M., Maurichi, A., Orgiano, L., Spadola, G., Del Vecchio, M., Danielli, R., Calabrò, L., Annesi, D., Giannarelli, D., Maccalli, C., Fonsatti, E., Parmiani, G., Maio, M.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article
Loading…
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Published in Journal of translational medicine (06.01.2021)
Published in Journal of translational medicine (06.01.2021)
Get full text
Journal Article
Loading…
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
Rossi, Niccolò, Lee, Karla A., Bermudez, Maria V., Visconti, Alessia, Thomas, Andrew Maltez, Bolte, Laura A., Björk, Johannes R., de Ruijter, Laura Kist, Newton-Bishop, Julia, Harland, Mark, Shaw, Heather M., Harries, Mark, Sacco, Joseph, Board, Ruth, Lorigan, Paul, de Vries, Elisabeth G.E., Segata, Nicola, Taams, Leonie S., Papa, Sophie, Spector, Tim D., Nathan, Paul, Weersma, Rinse K., Hospers, Geke A.P., Fehrmann, Rudolf S.N., Bataille, Veronique, Falchi, Mario
Published in EBioMedicine (01.09.2022)
Published in EBioMedicine (01.09.2022)
Get full text
Journal Article
Loading…
Phase Ib study of intratumoral oncolytic coxsackievirus A21 (CVA21) and pembrolizumab in subjects with advanced melanoma
Kaufman, H.L., Spencer, K., Mehnert, J., Silk, A., Wang, J., Zloza, A., Kane, M., Moore, D., Grose, M., Shafren, D.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Loading…
Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study
Kuzmanovszki, Daniella, Kiss, Norbert, Tóth, Béla, Kerner, Tünde, Tóth, Veronika, Szakonyi, József, Lőrincz, Kende, Hársing, Judit, Imrédi, Eleonóra, Pfund, Alexa, Szabó, Ákos, Brodszky, Valentin, Rencz, Fanni, Holló, Péter
Published in Biomedicines (19.07.2022)
Published in Biomedicines (19.07.2022)
Get full text
Journal Article
Loading…
Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma
Milhem, Mohammed, Gonzales, Rene, Medina, Theresa, Kirkwood, John M., Buchbinder, Elizabeth, Mehmi, Inderjit, Niu, Jiaxin, Shaheen, Montaser, Weight, Ryan, Margolin, Kim, Luke, Jason, Morris, Aaron, Mauro, David, Krieg, Arthur M., Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Loading…
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Published in Frontiers in oncology (10.01.2020)
Published in Frontiers in oncology (10.01.2020)
Get full text
Journal Article
Loading…
Loading…
Psychological impact of BRAF mutational status in advanced melanoma patients
Carli, Bernardo, Campolmi, Eleonora, Ciardetti, Isabella, Grifoni, Raffaella, Sestini, Serena, Pino, Maria S, Caligiani, Lucia, Borgognoni, Lorenzo, Pimpinelli, Nicola
Published in Italian journal of dermatology and venereology (01.04.2022)
Published in Italian journal of dermatology and venereology (01.04.2022)
Get more information
Journal Article
Loading…
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
Kyte, Jon Amund, Aamdal, Steinar, Dueland, Svein, Sæbøe-Larsen, Stein, Inderberg, Else Marit, Madsbu, Ulf Erik, Skovlund, Eva, Gaudernack, Gustav, Kvalheim, Gunnar
Published in Oncoimmunology (01.11.2016)
Published in Oncoimmunology (01.11.2016)
Get full text
Journal Article